Dabigatran etexilate

November 15, 2010
Image of Dabigatran etexilate 3D Image of Dabigatran etexilate

Dabigatran etexilate is an anticoagulant drug developed and marketed by Boehringer Ingelheim. The parent compound, dabigatran, is a potent thrombin blocker, but it cannot be administered orally. Adding the hydrophobic carbohexoxy group (“etexilate”) to the imine nitrogen created an orally absorbable prodrug.

Chemical Abstract Service - a division of ACS

Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.